Related Experiment Videos
Abnormal sensory evoked potentials in amyotrophic lateral sclerosis
Neurology
|June 1, 1986
Summary
Sensory evoked potentials (EPs) reveal central nervous system (CNS) sensory dysfunction in nearly half of amyotrophic lateral sclerosis (ALS) patients. These findings suggest more frequent sensory system involvement in ALS than previously recognized.
Area of Science:
- Neurology
- Neurophysiology
- Clinical Neuroscience
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease primarily affecting motor neurons.
- While motor symptoms are predominant, sensory system involvement in ALS is increasingly recognized but not fully understood.
- Evoked potentials (EPs) are electrophysiological tests that measure the brain's response to sensory stimulation, offering objective measures of sensory pathway integrity.
Purpose of the Study:
- To investigate the prevalence and patterns of sensory nervous system dysfunction in patients with amyotrophic lateral sclerosis (ALS) using various evoked potential (EP) modalities.
- To determine if EP findings provide evidence of central nervous system (CNS) sensory involvement in ALS.
- To compare EP findings with clinical and pathological observations of sensory system involvement in ALS.
Main Methods:
- A retrospective review of sensory evoked potential (EP) findings was conducted in 17 patients diagnosed with amyotrophic lateral sclerosis (ALS).
- Somatosensory EPs (SSEPs) were assessed following lower- and upper-extremity stimulation.
- Brainstem auditory EPs (BAEPs) and pattern reversal visual EPs (VEPs) were also evaluated in subsets of patients.
Main Results:
- Abnormalities in somatosensory EPs were detected in 7 of 16 patients after lower-extremity stimulation and 2 of 16 after upper-extremity stimulation.
- Brainstem auditory EP abnormalities were identified in 2 of 12 patients.
- No abnormalities were observed in pattern reversal visual EPs among 12 patients, with overall 47% of all studied ALS patients exhibiting at least one EP abnormality.
Conclusions:
- Evoked potential (EP) testing demonstrates evidence of central nervous system (CNS) sensory dysfunction in a significant proportion of amyotrophic lateral sclerosis (ALS) patients.
- The frequency of EP-detected sensory abnormalities in ALS surpasses that typically observed through clinical examination or post-mortem pathology.
- These findings support the hypothesis of sensory system involvement in the pathophysiology of ALS, highlighting the utility of EPs in characterizing the full spectrum of the disease.